BioNTech, Fosun Pharma get full regulatory approval for COMIRNATY in individuals 12 years and older in Hong Kong Ruchika Sharma27 Dec 2022 1:30 PM ISTShanghai: BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have announced that the Fosun Industrial Co., Limited (as a...
Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit Ruchika Sharma24 Dec 2022 12:30 PM ISTModerna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 3:31 PM ISTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
COVID vaccine: SII seeks DCGI nod for market authorisation of Covovax as booster dose Ruchika Sharma23 Dec 2022 2:30 PM ISTNew Delhi: The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19 vaccine Covovax as a...
Bivalent mRNA booster vaccine reduces risk of severe COVID-19 by more than half: CDC Medha Baranwal20 Dec 2022 9:45 AM ISTUSA: Updated bivalent (two-strain) mRNA booster shots reduce the risk of contracting severe COVID-19 by up to 57%, a recent study in Morbidity and...
European Commission approves Qdenga as second dengue virus vaccine Dr. Kamal Kant Kohli20 Dec 2022 7:45 AM ISTGlobally incidence of infection of dengue virus has increased 8-fold in the past 20 years and has become endemic in most tropical European Overseas...
New Tomato flu variant creates health scare among kids in several states MD Bureau18 Dec 2022 10:05 AM ISTNo antiviral drugs or vaccines are available for the treatment or prevention of Tomato Flu.
S pneumoniae infection treatment: DCGI nod to Biological E 14-valent paediatric Pneumococcal Conjugate Vaccine Ruchika Sharma17 Dec 2022 11:33 AM ISTBE’s PCV14 is comparable in terms of serotype coverage for infants to the two globally approved pneumococcal conjugate vaccines Prevenar13 and Merck’s...
COVID-19 vaccination more protective against death and hospitalization compared to natural immunity Dr. Kamal Kant Kohli17 Dec 2022 11:30 AM ISTUSA: Researchers have found in a new study that there are significantly lower rates of hospitalizations, all-cause emergency department (ED)...
Bharat Serums and Vaccines to buy Firstline Pharma, Genomicks to expand presence in women's health in Malaysia Ruchika Sharma16 Dec 2022 11:28 AM ISTNew Delhi: Bharat Serums and Vaccines Limited (BSV), a biopharmaceutical company in India has entered into a definitive agreement to acquire...
SII Cervical cancer vaccine CERVAVAC likely to be launched in April next year Ruchika Sharma15 Dec 2022 1:00 PM ISTSerum Institute's vaccine is likely to be available at a much lower rate.
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030 Ruchika Sharma13 Dec 2022 12:13 PM ISTNew York: Pfizer Inc said on Monday that annual revenue from its mRNA vaccine portfolio could reach $10 billion to $15 billion by 2030, alleviating...
